Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00140998 · ClinicalTrials.gov registry record · Phase 3
Estrogen Treatment (Oral vs. Patches) in Turner Syndrome
A Phase 3 study, sponsored by Nemours Children's Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 16
- Enrollment target
NCT00140998 is a Phase 3 study that has completed, run by Nemours Children's Clinic. The registered enrollment target is 16 participants.
The verdict
NCT00140998, a Phase 3 study, has completed, sponsored by Nemours Children's Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 16 participants
- Enrollment target
Study Summary
The study attempts to evaluate if the way of administering estrogen, the principal female hormone, via patches or orally, affects the way estrogen works in girls with Turner Syndrome. These are girls who are very short and whose ovaries do not work. We will examine changes bone, protein and fat metabolism under the influence of estrogen delivered by a patch trough the skin vs estrogen taken orally. These studies are conducted while the girls are taking GH therapy.
Interventions
- DRUG 17 beta estradiol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2001-01 |
| Est. Completion | 2004-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00140998
The ClinicalTrials.gov registry entry for NCT00140998 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nemours Children's Clinic, which has 108 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 17 beta estradiol is the first listed.
NCT00140998 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00140998 about?
NCT00140998 is a clinical study titled "Estrogen Treatment (Oral vs. Patches) in Turner Syndrome". The study attempts to evaluate if the way of administering estrogen, the principal female hormone, via patches or orally, affects the way estrogen works in girls with Turner Syndrome. These are girls who are very short and whose ovaries do not work. We will examine changes bone, protein and fat meta...
What is the current status of trial NCT00140998?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 16 participants. The study started on 2001-01. Estimated completion is 2004-06.
What interventions are being tested in trial NCT00140998?
The interventions under investigation include: 17 beta estradiol (DRUG).
Who is sponsoring clinical trial NCT00140998?
This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.